GCVRZ Message Board Post 8924868 | Sanofi Contingent Value...
home / stock / gcvrz / gcvrz message board
bahaneku
(investorshub)
Posted on: Dec/12/2016 19:55:25
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=127191890
Lemtrada Targets Circulating Innate Immune Cells in RRMS Patients https://multi
News, Short Squeeze, Breakout and More Instantly...
Sanofi Contingent Value Right (Expiring 12/31/2020) Company Name:
GCVRZ Stock Symbol:
Market:
-
* The British Pharmacological Society awards Cablivi® (caplacizumab), the first new treatment in 30 years for acquired Thrombotic Thrombocytopenic Purpura (aTTP), Drug Discovery of the Year 2020 * TTP is a rare blood clotting disorder with 330 people known to be affected i...